Stock listing

NASDAQ:ANIX Anixa Biosciences, Inc. Stock

Home listing (NASDAQ) of Anixa Biosciences, Inc.

Follow Anixa Biosciences, Inc. into a list and get an email when it puts out news.

Share price · NASDAQ:ANIX

$2.44 USD -0.27 (-10.0%)

Close on Nov 20, 2026

Past year -44.5% · daily closes, Nov 20, 2025 – Nov 20, 2026, adjusted for splits
Day range
$2.40 – $2.59 USDNov 20, 2026
Volume
355,051 sharesNov 20, 2026
Market cap
$84.82M USDAt the close on Nov 20, 2026 · price × 34.76M shares outstanding
52-week range
$2.32 – $5.46 USDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
Traded on an average day
$827,423 USDMedian day 277,549 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026
Anixa Biosciences, Inc. logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
NASDAQ:ANIX · Home$2.44 USD-0.27 (-10.0%)355,051$2.55$2.59$2.40$2.71Close on Nov 20, 2026
Frankfurt:CY71€2.335 EUR-0.12 (-4.9%)—€2.335€2.335€2.335€2.455Close on Nov 20, 2026

Daily closes

Last 3 months, Aug 20, 2026 – Nov 20, 2026 · NASDAQ:ANIX · USD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$2.44-0.27-10.0%$2.55$2.59$2.40355,051
$2.71+0.04+1.5%$2.70$2.83$2.64287,727
$2.67+0.12+4.7%$2.55$2.72$2.55228,036
$2.55-0.07-2.7%$2.61$2.697$2.54123,930
$2.62-0.06-2.2%$2.71$2.72$2.57278,633
$2.68-0.10-3.6%$2.72$2.845$2.66276,085
$2.78-0.28-9.2%$3.07$3.11$2.77277,549
$3.06-0.10-3.2%$3.14$3.18$3.04155,571
$3.16-0.015-0.5%$3.21$3.30$3.094126,713
$3.175+0.145+4.8%$3.02$3.175$2.99121,587
$3.03-0.25-7.6%$3.27$3.27$3.00201,025
$3.28+0.225+7.4%$3.11$3.32$3.05218,312
$3.055+0.065+2.2%$3.04$3.19$3.02149,606
$2.99-0.13-4.2%$3.14$3.151$2.99128,338
$3.12-0.18-5.5%$3.28$3.35$3.10140,407
$3.30-0.07-2.1%$3.40$3.439$3.28135,738
$3.37+0.09+2.7%$3.26$3.43$3.20251,324
$3.28+0.35+11.9%$2.95$3.34$2.945497,331
$2.93-0.06-2.0%$2.94$2.98$2.90135,562
$2.99+0.21+7.6%$2.80$3.14$2.74326,677
$2.78+0.07+2.6%$2.70$2.78$2.68154,000
$2.71+0.03+1.1%$2.68$2.75$2.66115,700
$2.68+0.07+2.7%$2.64$2.75$2.64163,100
$2.61-0.06-2.2%$2.67$2.69$2.6091,300
$2.67-0.11-4.0%$2.79$2.82$2.65123,400
$2.78+0.12+4.5%$2.66$2.79$2.63223,300
$2.66-0.01-0.4%$2.75$2.82$2.63228,400
$2.67-0.17-6.0%$2.84$2.84$2.66175,400
$2.84-0.06-2.1%$2.90$2.92$2.8397,700
$2.90-0.01-0.3%$2.93$2.96$2.86217,900
$2.91-0.04-1.4%$2.93$2.93$2.86259,600
$2.95-0.07-2.3%$3.01$3.06$2.93245,200
$3.02+0.07+2.4%$2.95$3.11$2.87344,900
$2.950.000.0%$2.98$2.99$2.88369,300
$2.95+0.18+6.5%$2.83$2.95$2.77433,300
$2.77-0.16-5.5%$2.93$2.93$2.74290,400
$2.93+0.08+2.8%$2.85$2.95$2.81428,900
$2.85+0.06+2.2%$2.79$2.85$2.72183,200
$2.79+0.01+0.4%$2.78$2.83$2.70305,500
$2.780.000.0%$2.85$2.87$2.69360,800
$2.78+0.03+1.1%$2.74$2.81$2.72257,700
$2.75-0.04-1.4%$2.77$2.81$2.62391,100
$2.79+0.09+3.3%$2.73$2.79$2.68434,100
$2.70-0.07-2.5%$2.82$2.82$2.66476,300
$2.77+0.01+0.4%$2.78$2.79$2.69315,200
$2.76+0.16+6.2%$2.66$2.76$2.64345,600
$2.60-0.09-3.3%$2.70$2.72$2.56557,400
$2.69-0.11-3.9%$2.80$2.80$2.66353,700
$2.80+0.04+1.4%$2.79$2.88$2.76376,400
$2.76+0.01+0.4%$2.87$2.88$2.72389,300
$2.75-0.08-2.8%$2.76$2.81$2.66400,100
$2.83-0.07-2.4%$2.92$2.97$2.79476,600
$2.90-0.17-5.5%$3.10$3.20$2.88441,200
$3.07+0.02+0.7%$3.03$3.11$3.00367,900
$3.05-0.08-2.6%$3.14$3.25$2.99409,100
$3.13-0.15-4.6%$3.28$3.39$3.12334,700
$3.28-0.07-2.1%$3.41$3.49$3.23342,200
$3.35-0.13-3.7%$3.43$3.63$3.31353,300
$3.48-0.12-3.3%$3.60$3.67$3.42214,700
$3.60-0.01-0.3%$3.60$3.68$3.52337,300
$3.61-0.05-1.4%$3.64$3.75$3.47291,300
$3.66+0.04+1.1%$3.64$3.87$3.62607,300
$3.62-0.09-2.4%$3.66$3.73$3.51138,800
$3.71+0.12+3.3%$3.64$3.76$3.60182,400
$3.59-0.12-3.2%$3.69$3.71$3.55168,500

Splits

5 splits since 1985 · NASDAQ:ANIX · every price before a split is adjusted for it

DayRatioWhat
1-for-25Consolidation
2-for-1Split
2-for-1Split
5-for-4Split
3-for-1Split
Ticker
NASDAQ:ANIX
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
NASDAQ
Currency
USD

What changed lately

Latest news

All Anixa Biosciences, Inc. news

Anixa Biosciences, Inc. on 6ix

Sector
Health care
Industry
Biotechnology
News releases
41 in the last 12 months · 186 in all · newest Nov 19, 2026 · oldest 2019
Decks
18 decks · latest November 2026

Where Anixa Biosciences, Inc. is listed

ListingExchangeCountryCurrency
NASDAQ:ANIX · Home listing · This pageNASDAQUnited StatesUSD
gettex:CY71gettexGermanyEUR
LS Exchange:A2N6ZFLS ExchangeGermanyEUR
Lang & Schwarz:A2N6ZFLang & SchwarzGermanyEUR
Frankfurt:CY71FrankfurtGermanyEUR
Tradegate:CY71TradegateGermanyEUR
BOATS:ANIXBOATSUnited StatesUSD
Munich:CY71MunichGermanyEUR
Dusseldorf:CY71DusseldorfGermanyEUR
Hamburg:CY71HamburgGermanyEUR
Stuttgart:CY71StuttgartGermanyEUR

Valuation

Price/book 5.9× against a median of 2.0×: the highest of 10 Biotechnology companies shown. Statements: 4 quarters to Jul 31, 2026 · price Nov 20, 2026

Enterprise value
$70.96M USD
P/E
Loss
EV/sales
No revenue
EV/EBITDA
No depreciation figure on 6ix yet
Price/book
5.9×
Gross margin
No revenue
Operating margin
No revenue
Net margin
No revenue
Debt to equity
0.0×
Beta vs S&P 500
1.45

Biotechnology: the 10 companies nearest in size, of 890 on 6ix with figures. Size in US dollars.

CompanyMkt capEVP/EEV/SalesEV/EBITDAP/BNet mgnDebt/EqBeta
Anixa Biosciences, Inc. · NASDAQ:ANIXUS$84.82MUS$70.96Mn/an/an/a5.9×n/a0.0×1.45
Upstream Bio, Inc. · NASDAQ:UPBUS$87.15M−US$119.4Mn/a−41.6×n/a0.4×n/a0.0×1.95
Senhwa Biosciences Inc · TPEX:6492US$86.77MUS$67.44Mn/a2,117×n/a4.6×n/a0.0×n/a
Bioceltix SA · GPW:BCXUS$86.32MUS$72.38Mn/an/an/a5.6×n/a0.0×n/a
Perspective Therapeutics, Inc. · AMEX:CATXUS$86.05M−US$114.1Mn/a−570×n/a0.3×n/a0.0×1.47
Pharmosa Biopharm Inc. · TPEX:6875US$86.04MUS$62.27Mn/a38.5×n/a2.1×−658.1%0.1×n/a
Formosa Pharmaceuticals, Inc. · TWSE:6838US$85.44MUS$48.52Mn/a30.4×n/a2.0×−361.4%0.0×n/a
Genome & Co. · KRX:314130US$84.78MUS$36.99Mn/a2.0×n/a1.6×−169.1%0.0×n/a
BetterLife Pharma Inc. · CSE:BETRUS$84.03MUS$83.37Mn/an/an/an/an/an/a1.14
Shine-On Biomedical Co., Ltd. · TPEX:6926US$83.56MUS$59.02Mn/a64.8×n/a3.5×−367.6%0.0×n/a
Rallybio Corporation · NASDAQ:RLYBUS$83.29M−US$7.40M3.1×−17.1×n/a0.9×n/a0.0×0.58
Median of the othersUS$85.74MUS$53.77M3.1×16.2×2.0×−364.5%0.0×1.31

Forecasts

2 strong buy · 1 buy · Analysts' consensus from EODHD, read Nov 16, 2026. Not 6ix's view and not investment advice.

Price target
9.67 USD · Analysts' mean
EPS, year to Oct 2026
-0.31 · 1 analyst

Team and board

Officers

OfficerRole
Amit KumarChairman of the Board & CEO
Michael CatelaniPresident, COO & CFO

Board

DirectorRole
Amit KumarChairman of the Board & CEO
Arnold BaskiesDirector
Emily GottschalkDirector
Lew TittertonLead Independent Director
Michael CatelaniPresident, COO & CFO

Events

Next results
Jan 11, 2027 (expected)
QuarterResultsShare move
Q3 2026Sep 9, 2026 · After close−2.8%
Q2 2026Jun 10, 2026 · After close+5.5%
Q1 2026Mar 9, 2026 · After close0.0%
Q4 2025Jan 7, 2026+7.5%
Q3 2025Sep 10, 2025 · After close−2.3%
Q2 2025May 28, 2025 · After close+2.8%
Q1 2025Mar 21, 2025 · After close+1.3%
Q4 2024Jan 10, 2025 · After close−2.7%
Q3 2024Sep 6, 2024 · After close−1.3%
Q2 2024Jun 4, 2024 · After close−2.0%
All 20 quarters
QuarterResultsShare move
Q1 2024Mar 12, 2024 · After close+3.3%
Q4 2023Jan 16, 2024 · After close−8.6%
Q3 2023Sep 6, 2023 · After close−5.7%
Q2 2023Jun 14, 2023 · After close+4.6%
Q1 2023Mar 17, 2023 · Before open−8.9%
Q4 2022Jan 4, 2023 · After close−3.3%
Q3 2022Sep 9, 2022 · After close+8.7%
Q2 2022Jun 10, 2022 · After close−9.0%
Q1 2022Mar 11, 2022 · After close−5.6%
Q4 2021Jan 4, 2022 · After close−9.2%

Open Events

Decks

DeckKindSlidesDate
Investor Presentation (November 2026)Investor deck24 slidesNovember 2026
Investor Presentation (October 2026)Investor deck24 slidesOctober 2026
Investor Presentation (September 2026)Investor deck23 slidesSeptember 2026
Investor Presentation (March 2026)Investor deck21 slidesMar 11, 2026
Shareholder Meeting (March 2025)Shareholder meeting38 slidesMar 21, 2025
Shareholder Meeting (March 2024)Shareholder meeting34 slidesMar 22, 2024
Investor Presentation (March 2023)Investor deck22 slidesMar 10, 2023
Technical Presentation (September 2022)Technical12 slidesSep 29, 2022
Investor Presentation (March 2022)Investor deck27 slidesMar 11, 2022
Investor Presentation (May 2021)Investor deck16 slidesMay 27, 2021
All 18 decks
DeckKindSlidesDate
Investor Presentation (September 2020)Investor deck16 slidesSep 16, 2020
Investor Presentation (August 2020)Investor deck19 slidesAug 17, 2020
Shareholder Meeting (October 2019)Shareholder meeting23 slidesOct 24, 2019
Investor Presentation (August 2019)Investor deck22 slidesAug 21, 2019
Investor Presentation (May 2019)Investor deck22 slidesMay 23, 2019
ITUS — Shareholder Meeting (September 2018)Shareholder meeting15 slidesSep 27, 2018
ITUS — Investor Presentation (June 2017)Investor deck25 slidesJun 2, 2017
Copytele — Investor Presentation (October 2012)Investor deck13 slidesOct 10, 2012

Open Decks

Financials

Annual, in USD

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue210.0K210.0K512.0K250.0K1.11M362.5K300.0K
Research and development5.07M6.40M4.77M6.70M6.19M4.38M5.47M6.81M1.60M1.56M
Selling, general and administrative5.66M6.91M4.41M2.71M
Operating income-11.7M-13.8M-11.0M-13.9M-13.1M-9.98M-11.9M-14.3M-6.08M-4.51M
Depreciation and amortization38.3K47.6K18.4K43.2K33.3K
EBITDA-9.94M-11.8M-14.3M-6.03M-4.48M
Interest expense500.5K519.9K
Income before tax-11.8M-14.2M-5.01M-5.02M
Net income-10.9M-12.6M-9.81M-13.6M-13.0M-10.0M-11.6M-14.0M-5.01M-5.02M
Earnings per share, basic-0.34-0.39-0.320.45-0.45-0.45-0.59-0.79-0.58-0.57
Earnings per share, diluted-0.34-0.39-0.320.45-0.45-0.45-0.59-0.79-0.58-0.57

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash and equivalents1.24M1.27M915.0K12.4M29.1M6.42M3.49M3.06M3.34M2.49M
Short-term investments13.9M18.7M22.9M17.3M6.60M2.64M2.35M2.00M3.50M750.0K
Receivables173.0K270.0K46.0K2.23K66.5K307.0K
Current assets15.9M21.4M25.4M30.2M36.0M9.37M6.09M5.54M7.01M3.40M
Property, plant and equipment200.6K72.7K52.7K156.6K
Total assets16.1M21.6M25.5M30.4M36.3M9.45M6.29M6.45M8.81M5.63M
Accounts payable165.0K525.0K206.0K265.0K136.0K232.4K585.8K582.0K480.3K373.2K
Current liabilities1.97M2.50M2.03M2.04M1.27M1.19M1.48M1.27M889.5K468.8K
Total liabilities2.13M2.70M2.15M2.21M1.49M1.19M1.48M889.5K4.64M
Shareholders' equity15.2M20.0M24.3M29.0M35.4M8.76M5.24M5.43M7.92M987.5K
Shares outstanding33.0M32.2M31.1M30.9M30.1M24.2M20.3M18.9M16.6M8.75M

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations-7.17M-7.33M-6.21M-6.49M-4.94M-6.18M-4.74M-4.27M-3.80M-3.38M
Capital spending-15.8K-175.5K-38.4K-30.2K-146.5K
Free cash flow-6.19M-4.92M-4.31M-3.83M-3.53M
Cash from investing4.87M4.28M-5.60M-10.7M-3.92M-305.8K-525.5K1.46M-2.74M1.50M
Cash from financing2.28M3.42M366.0K452.0K31.6M9.41M5.70M2.53M7.38M-2.68K
Share buybacks-6.00K
Change in cash-27.0K356.0K-11.4M-16.8M22.7M2.93M435.7K-283.5K851.1K-1.88M

Open Financials

Filings

FilingDateTypeFiled with
4 · Change in ownershipNov 2, 2026Insider tradeSEC
4 · Change in ownershipOct 26, 2026Insider tradeSEC
4 · Change in ownershipOct 22, 2026Insider tradeSEC
4 · Change in ownershipSep 30, 2026Insider tradeSEC
4 · Change in ownershipSep 28, 2026Insider tradeSEC
4 · Change in ownershipSep 28, 2026Insider tradeSEC
4 · Change in ownershipSep 25, 2026Insider tradeSEC
4 · Change in ownershipSep 14, 2026Insider tradeSEC
4 · Change in ownershipSep 14, 2026Insider tradeSEC
4 · Change in ownershipSep 11, 2026Insider tradeSEC
Show 200 filings
FilingDateTypeFiled with
10-Q · Quarterly reportSep 9, 2026Quarterly reportSEC
4 · Change in ownershipAug 3, 2026Insider tradeSEC
4 · Change in ownershipJul 29, 2026Insider tradeSEC
4 · Change in ownershipJul 28, 2026Insider tradeSEC
4 · Change in ownershipJul 27, 2026Insider tradeSEC
4 · Change in ownershipJul 27, 2026Insider tradeSEC
4 · Change in ownershipJul 21, 2026Insider tradeSEC
4 · Change in ownershipJul 20, 2026Insider tradeSEC
4 · Change in ownershipJul 16, 2026Insider tradeSEC
4 · Change in ownershipJul 13, 2026Insider tradeSEC
4 · Change in ownershipJun 17, 2026Insider tradeSEC
4 · Change in ownershipJun 16, 2026Insider tradeSEC
10-Q · Quarterly reportJun 10, 2026Quarterly reportSEC
8-K · Current reportMar 11, 2026Meeting outcomeSEC
10-Q · Quarterly reportMar 9, 2026Quarterly reportSEC
8-K · Current reportFeb 9, 2026Current reportSEC
4 · Change in ownershipJan 29, 2026Insider tradeSEC
DEF 14A · Proxy statementJan 28, 2026Meeting noticeSEC
S-8 · Registration statement for employee plansJan 12, 2026Offer documentSEC
10-K · Annual reportJan 12, 2026Annual reportSEC
SCHEDULE 13D/A · Big-stake notice, amendedJan 6, 2026Big-stake noticeSEC
4 · Change in ownershipJan 6, 2026Insider tradeSEC
4 · Change in ownershipJan 6, 2026Insider tradeSEC
4 · Change in ownershipJan 6, 2026Insider tradeSEC
4 · Change in ownershipJan 6, 2026Insider tradeSEC
4 · Change in ownershipJan 6, 2026Insider tradeSEC
4 · Change in ownershipDec 16, 2025Insider tradeSEC
8-K · Current reportDec 11, 2025Current reportSEC
4 · Change in ownershipOct 31, 2025Insider tradeSEC
EFFECT · Notice that a registration is effectiveOct 1, 2025Other filingsSEC
CORRESP · Letter to the SECSep 26, 2025Other filingsSEC
UPLOAD · Letter from the SECSep 16, 2025Other filingsSEC
S-3 · Registration statementSep 10, 2025Offer documentSEC
10-Q · Quarterly reportSep 10, 2025Quarterly reportSEC
4 · Change in ownershipAug 4, 2025Insider tradeSEC
4 · Change in ownershipJul 31, 2025Insider tradeSEC
4 · Change in ownershipJul 21, 2025Insider tradeSEC
4 · Change in ownershipJul 15, 2025Insider tradeSEC
4 · Change in ownershipJul 14, 2025Insider tradeSEC
SCHEDULE 13D/A · Big-stake notice, amendedJun 6, 2025Big-stake noticeSEC
4 · Change in ownershipJun 5, 2025Insider tradeSEC
10-Q · Quarterly reportMay 28, 2025Quarterly reportSEC
8-K · Current reportMar 21, 2025Meeting outcomeSEC
10-Q · Quarterly reportMar 11, 2025Quarterly reportSEC
DEF 14A · Proxy statementFeb 6, 2025Meeting noticeSEC
4 · Change in ownershipJan 29, 2025Insider tradeSEC
4 · Change in ownershipJan 27, 2025Insider tradeSEC
4 · Change in ownershipJan 23, 2025Insider tradeSEC
4 · Change in ownershipJan 22, 2025Insider tradeSEC
4 · Change in ownershipJan 17, 2025Insider tradeSEC
4 · Change in ownershipJan 15, 2025Insider tradeSEC
4 · Change in ownershipJan 15, 2025Insider tradeSEC
S-8 · Registration statement for employee plansJan 10, 2025Offer documentSEC
10-K · Annual reportJan 10, 2025Annual reportSEC
SCHEDULE 13D/A · Big-stake notice, amendedJan 3, 2025Big-stake noticeSEC
4 · Change in ownershipJan 3, 2025Insider tradeSEC
4 · Change in ownershipJan 3, 2025Insider tradeSEC
4 · Change in ownershipJan 3, 2025Insider tradeSEC
4 · Change in ownershipJan 3, 2025Insider tradeSEC
4 · Change in ownershipJan 3, 2025Insider tradeSEC
8-K · Current reportNov 8, 2024Current reportSEC
4 · Change in ownershipOct 23, 2024Insider tradeSEC
10-Q · Quarterly reportSep 6, 2024Quarterly reportSEC
4 · Change in ownershipAug 1, 2024Insider tradeSEC
4 · Change in ownershipJul 29, 2024Insider tradeSEC
4 · Change in ownershipJul 26, 2024Insider tradeSEC
4 · Change in ownershipJun 18, 2024Insider tradeSEC
4 · Change in ownershipJun 14, 2024Insider tradeSEC
4 · Change in ownershipJun 12, 2024Insider tradeSEC
4 · Change in ownershipJun 10, 2024Insider tradeSEC
4 · Change in ownershipJun 7, 2024Insider tradeSEC
4 · Change in ownershipJun 7, 2024Insider tradeSEC
10-Q · Quarterly reportJun 4, 2024Quarterly reportSEC
8-K · Current reportMay 8, 2024Material contractSEC
SC 13D · Big-stake noticeMay 3, 2024Big-stake noticeSEC
4 · Change in ownershipMay 2, 2024Insider tradeSEC
4 · Change in ownershipApr 10, 2024Insider tradeSEC
8-K · Current reportMar 22, 2024Meeting outcomeSEC
4 · Change in ownershipMar 15, 2024Insider tradeSEC
4 · Change in ownershipMar 15, 2024Insider tradeSEC
10-Q · Quarterly reportMar 12, 2024Quarterly reportSEC
DEF 14A · Proxy statementFeb 8, 2024Meeting noticeSEC
4 · Change in ownershipJan 16, 2024Insider tradeSEC
4 · Change in ownershipJan 16, 2024Insider tradeSEC
4 · Change in ownershipJan 16, 2024Insider tradeSEC
4 · Change in ownershipJan 16, 2024Insider tradeSEC
4 · Change in ownershipJan 16, 2024Insider tradeSEC
SC 13D/A · Big-stake notice, amendedJan 16, 2024Big-stake noticeSEC
S-8 · Registration statement for employee plansJan 16, 2024Offer documentSEC
10-K · Annual reportJan 16, 2024Annual reportSEC
8-K · Current reportDec 7, 2023Current reportSEC
4 · Change in ownershipNov 2, 2023Insider tradeSEC
4 · Change in ownershipOct 11, 2023Insider tradeSEC
10-Q · Quarterly reportSep 6, 2023Quarterly reportSEC
4 · Change in ownershipJul 31, 2023Insider tradeSEC
4 · Change in ownershipJul 31, 2023Insider tradeSEC
4 · Change in ownershipJul 21, 2023Insider tradeSEC
10-Q · Quarterly reportJun 14, 2023Quarterly reportSEC
4 · Change in ownershipMay 1, 2023Insider tradeSEC
8-K · Current reportApr 17, 2023Current reportSEC
10-Q · Quarterly reportMar 16, 2023Quarterly reportSEC
8-K · Current reportMar 10, 2023Meeting outcomeSEC
DEF 14A · Proxy statementJan 27, 2023Meeting noticeSEC
4 · Change in ownershipJan 4, 2023Insider tradeSEC
4 · Change in ownershipJan 4, 2023Insider tradeSEC
4 · Change in ownershipJan 4, 2023Insider tradeSEC
4 · Change in ownershipJan 4, 2023Insider tradeSEC
4 · Change in ownershipJan 4, 2023Insider tradeSEC
S-8 · Registration statement for employee plansJan 4, 2023Offer documentSEC
10-K · Annual reportJan 4, 2023Annual reportSEC
8-K · Current reportDec 8, 2022Current reportSEC
4 · Change in ownershipNov 1, 2022Insider tradeSEC
4 · Change in ownershipSep 30, 2022Insider tradeSEC
8-K · Current reportSep 29, 2022Current reportSEC
EFFECT · Notice that a registration is effectiveSep 20, 2022Other filingsSEC
4 · Change in ownershipSep 16, 2022Insider tradeSEC
4 · Change in ownershipSep 16, 2022Insider tradeSEC
CORRESP · Letter to the SECSep 15, 2022Other filingsSEC
UPLOAD · Letter from the SECSep 14, 2022Other filingsSEC
DEL AMSep 12, 2022Other filingsSEC
S-3 · Registration statementSep 9, 2022Offer documentSEC
10-Q · Quarterly reportSep 9, 2022Quarterly reportSEC
8-K · Current reportAug 17, 2022Current reportSEC
4 · Change in ownershipJun 28, 2022Insider tradeSEC
10-Q · Quarterly reportJun 10, 2022Quarterly reportSEC
4 · Change in ownershipMay 2, 2022Insider tradeSEC
4 · Change in ownershipApr 27, 2022Insider tradeSEC
4 · Change in ownershipApr 22, 2022Insider tradeSEC
4 · Change in ownershipApr 21, 2022Insider tradeSEC
4 · Change in ownershipApr 15, 2022Insider tradeSEC
8-K · Current reportApr 15, 2022Management or board changeSEC
8-K · Current reportMar 11, 2022Meeting outcomeSEC
4 · Change in ownershipMar 11, 2022Insider tradeSEC
4 · Change in ownershipMar 11, 2022Insider tradeSEC
4 · Change in ownershipMar 11, 2022Insider tradeSEC
4 · Change in ownershipMar 11, 2022Insider tradeSEC
4 · Change in ownershipMar 11, 2022Insider tradeSEC
10-Q · Quarterly reportMar 11, 2022Quarterly reportSEC
DEF 14A · Proxy statementJan 28, 2022Meeting noticeSEC
4 · Change in ownershipJan 13, 2022Insider tradeSEC
4 · Change in ownershipJan 12, 2022Insider tradeSEC
4 · Change in ownershipJan 11, 2022Insider tradeSEC
4 · Change in ownershipJan 10, 2022Insider tradeSEC
4 · Change in ownershipJan 7, 2022Insider tradeSEC
S-8 · Registration statement for employee plansJan 4, 2022Offer documentSEC
10-K · Annual reportJan 4, 2022Annual reportSEC
8-K · Current reportDec 9, 2021Current reportSEC
4 · Change in ownershipNov 2, 2021Insider tradeSEC
4 · Change in ownershipNov 1, 2021Insider tradeSEC
4 · Change in ownershipNov 1, 2021Insider tradeSEC
8-K · Current reportOct 28, 2021Current reportSEC
8-K · Current reportOct 4, 2021Current reportSEC
SC 13D/A · Big-stake notice, amendedSep 3, 2021Big-stake noticeSEC
10-Q · Quarterly reportSep 1, 2021Quarterly reportSEC
4 · Change in ownershipJul 28, 2021Insider tradeSEC
4 · Change in ownershipJul 27, 2021Insider tradeSEC
4 · Change in ownershipJul 27, 2021Insider tradeSEC
4 · Change in ownershipJul 20, 2021Insider tradeSEC
4 · Change in ownershipJul 19, 2021Insider tradeSEC
4 · Change in ownershipJul 16, 2021Insider tradeSEC
4 · Change in ownershipJul 16, 2021Insider tradeSEC
4 · Change in ownershipJul 15, 2021Insider tradeSEC
8-K · Current reportJun 16, 2021Current reportSEC
10-Q · Quarterly reportJun 10, 2021Quarterly reportSEC
SC 13D/A · Big-stake notice, amendedJun 10, 2021Big-stake noticeSEC
4 · Change in ownershipJun 2, 2021Insider tradeSEC
4 · Change in ownershipJun 2, 2021Insider tradeSEC
4 · Change in ownershipJun 2, 2021Insider tradeSEC
4 · Change in ownershipJun 2, 2021Insider tradeSEC
4 · Change in ownershipJun 2, 2021Insider tradeSEC
8-K · Current reportMay 27, 2021Meeting outcomeSEC
4 · Change in ownershipMay 4, 2021Insider tradeSEC
4 · Change in ownershipApr 23, 2021Insider tradeSEC
4 · Change in ownershipApr 20, 2021Insider tradeSEC
4 · Change in ownershipApr 20, 2021Insider tradeSEC
DEF 14A · Proxy statementApr 9, 2021Meeting noticeSEC
8-K · Current reportApr 2, 2021Management or board changeSEC
PRE 14A · Preliminary proxy statementMar 30, 2021Meeting noticeSEC
4 · Change in ownershipMar 26, 2021Insider tradeSEC
4 · Change in ownershipMar 26, 2021Insider tradeSEC
4 · Change in ownershipMar 25, 2021Insider tradeSEC
4 · Change in ownershipMar 25, 2021Insider tradeSEC
8-K · Current reportMar 24, 2021Material contractSEC
424B5 · ProspectusMar 24, 2021Offer documentSEC
FWP · Free writing prospectusMar 22, 2021Offer documentSEC
FWP · Free writing prospectusMar 22, 2021Offer documentSEC
424B5 · ProspectusMar 22, 2021Offer documentSEC
10-Q · Quarterly reportMar 11, 2021Quarterly reportSEC
SC 13D/A · Big-stake notice, amendedFeb 5, 2021Big-stake noticeSEC
4 · Change in ownershipFeb 5, 2021Insider tradeSEC

This page holds 200 of 983 filings. Open Filings

Open Filings · All of its filings on SEC EDGAR

Cap table

Built by 6ix from Anixa Biosciences, Inc.’s releases · as of Sep 9, 2026

Common shares
34,763,802
Fully diluted
34,763,802

Fully diluted

LineSharesAs of
Common shares34,763,802Sep 9, 2026

Share count over time

CountShares
Sep 9, 202634,763,802

Open Cap table

Shareholders

Institutions

HolderSharesOf the companyValueChange vs Jun 30Filed
Vanguard1.55M4.5%US$4.54M+17,857Nov 13, 2026
Marshall Wace, LLP808K2.3%US$2.37M+480KNov 13, 2026
Laird Norton Wetherby Trust Company, LLC601K1.7%US$1.76M+22,000Nov 16, 2026
UBS587K1.7%US$1.72M+1,385Nov 10, 2026
D.A. Davidson & Co.495K1.4%US$1.45M−44,323Oct 27, 2026
Geode Capital342K0.98%US$1M−17,554Nov 6, 2026
Renaissance Technologies301K0.86%US$881K+241KNov 12, 2026
BlackRock195K0.56%US$571K−4,949Nov 13, 2026
Gsa Capital Partners LLP181K0.52%US$530K+63,554Nov 16, 2026
State Street159K0.46%US$466KNo changeNov 12, 2026
Show 50 holders
HolderSharesOf the companyValueChange vs Jun 30Filed
LPL Financial LLC115K0.33%US$336K+3,300Nov 6, 2026
Two Sigma102K0.29%US$298KNewNov 16, 2026
Northern Trust69,2350.20%US$203KNo changeNov 16, 2026
CoreCap Advisors, LLC62,0200.18%US$182K+10,000Oct 8, 2026
Susquehanna54,9260.16%US$161KNewNov 16, 2026
CIBC53,2000.15%US$156K+26,600Nov 13, 2026
BNY47,4420.14%US$139KNo changeNov 5, 2026
Westside Investment Management, Inc.43,0000.12%US$126KNo changeNov 2, 2026
Kestra Advisory Services, LLC40,5000.12%US$119K+2,500Nov 19, 2026
HighTower Advisors, LLC39,3800.11%US$115K−1,770Nov 9, 2026
Corient Private Wealth LP37,4000.11%US$110KNo changeNov 16, 2026
First Affirmative Financial Network36,0000.10%US$105KFirst reportOct 21, 2026
Gemmer Asset Management LLC35,0000.10%US$103KNo changeOct 16, 2026
Modern Wealth Management, LLC32,0000.09%US$93,760No changeNov 16, 2026
Vontobel Holding Ltd.30,0000.09%US$87,900No changeOct 16, 2026
Morgan Stanley23,3960.07%US$68,550+17,253Nov 13, 2026
Jump Financial, LLC22,8030.07%US$66,813NewNov 13, 2026
Nations Financial Group Inc, /Ia/22,5000.06%US$65,925No changeNov 5, 2026
Citadel19,9610.06%US$58,486−11,926Nov 16, 2026
Axq Capital, LP19,2440.06%US$56,385+4,611Nov 12, 2026
Keybank National Association15,8100.05%US$46,323No changeNov 4, 2026
Robertson Stephens Wealth Management, LLC15,6490.05%US$45,852No changeOct 16, 2026
Dakota Wealth Management15,0000.04%US$43,950No changeNov 12, 2026
Continuum Wealth Advisors, LLC13,7520.04%US$40,293NewOct 20, 2026
CPP Investments13,5000.04%US$39,555No changeNov 16, 2026
Schwab12,7850.04%US$37,460−13Nov 16, 2026
Simplicity Wealth,LLC12,0000.03%US$35,160No changeOct 23, 2026
Wells Fargo12,0000.03%US$35,160No changeNov 16, 2026
Benjamin Edwards Inc11,2000.03%US$32,816No changeNov 12, 2026
Integrated Wealth Concepts LLC10,9850.03%US$32,186+100Nov 16, 2026
Aptus Capital Advisors, LLC10,9850.03%US$32,186+100Nov 13, 2026
Northwestern Mutual Wealth Management Co10,5000.03%US$30,765No changeNov 13, 2026
Private Advisor Group, LLC10,4210.03%US$30,534+200Nov 10, 2026
Equitable Holdings, Inc.10,2450.03%US$30,018NewNov 16, 2026
Cherry Creek Investment Advisors, Inc.10,0260.03%US$29,376NewOct 14, 2026
Staley Capital Advisers Inc10,0000.03%US$29,300No changeNov 6, 2026
BFC Planning, Inc.10,0000.03%US$29,300No changeNov 13, 2026
Group One Trading LLC9,9710.03%US$29,215−3,560Nov 10, 2026
JPMorgan7,2750.02%US$20,734+5,185Nov 12, 2026
Jones Financial Companies Lllp5,3170.02%US$14,781+790Nov 13, 2026

This page holds 50 of 73 holders. Open Shareholders

Funds

HolderSharesOf the companyValueChangeAs of
Vanguard Total Stock Market Index Fund937K2.7%US$2.62MNo changeJun 30, 2026
Vanguard Extended Market Index Fund354K1.0%US$991K+14,870Jun 30, 2026
Fidelity Extended Market Index Fund167K0.48%US$452K+2,625May 31, 2026
iShares Micro-Cap ETF107K0.31%US$301K+27,650Jun 30, 2026
Fidelity Total Market Index Fund52,6940.15%US$142KNo changeMay 31, 2026
Fidelity Series Total Market Index Fund46,6450.13%US$126K+3,315May 31, 2026
Fidelity Nasdaq Composite Index Fund24,1020.07%US$65,075No changeMay 31, 2026
Vanguard Institutional Total Stock Market Index Fund21,0790.06%US$59,021No changeJun 30, 2026
Vanguard Balanced Index Fund17,9680.05%US$50,310No changeJun 30, 2026
Schwab Total Stock Market Index Fund12,7850.04%US$43,725No changeJul 31, 2026
All 11 holders
HolderSharesOf the companyValueChangeAs of
1290 VT Micro Cap Portfolio7,2050.02%US$20,174+1,477Jun 30, 2026

Insider trades

InsiderTradeSharesPriceValueDate
Kumar Amit
Director, Officer: Chief Executive Officer
Buy5,000USD 3.17US$15,850Oct 30, 2026
Titterton Lewis H jr
Director
Buy8,000USD 2.98US$23,840Oct 23, 2026
Kumar Amit
Director, Officer: Chief Executive Officer
Buy8,000USD 2.72US$21,760Oct 22, 2026
Catelani Michael
Officer: President, COO, & CFO
Buy5,500USD 2.84US$15,620Sep 30, 2026
Baskies Arnold M
Director
Buy5,000USD 2.76US$13,800Sep 24, 2026
Kumar Amit
Director, Officer: Chief Executive Officer
Buy7,000USD 2.78US$19,460Sep 24, 2026
Titterton Lewis H jr
Director
Buy49,036USD 2.69US$132KSep 23, 2026
Titterton Lewis H jr
Director
Buy10,000USD 2.73US$27,300Sep 10, 2026
Kumar Amit
Director, Officer: Chief Executive Officer
Buy3,000USD 2.75US$8,250Sep 10, 2026
Kumar Amit
Director, Officer: Chief Executive Officer
Buy5,000USD 2.76US$13,800Sep 10, 2026
All 20 trades
InsiderTradeSharesPriceValueDate
Kumar Amit
Director, Officer: Chief Executive Officer
Buy5,000USD 3.47US$17,350Jul 31, 2026
Kumar Amit
Director, Officer: Chief Executive Officer
Buy5,000USD 3.44US$17,200Jul 27, 2026
Kumar Amit
Director, Officer: Chief Executive Officer
Buy3,188USD 3.37US$10,744Jul 27, 2026
Kumar Amit
Director, Officer: Chief Executive Officer
Buy3,000USD 3.73US$11,190Jul 24, 2026
Kumar Amit
Director, Officer: Chief Executive Officer
Buy5,000USD 3.46US$17,300Jul 20, 2026
Titterton Lewis H jr
Director
Buy12,000USD 3.47US$41,640Jul 20, 2026
Titterton Lewis H jr
Director
Buy2,797USD 3.28US$9,174Jul 15, 2026
Kumar Amit
Director, Officer: Chief Executive Officer
Buy5,000USD 3.04US$15,200Jul 10, 2026
Titterton Lewis H jr
Director
Buy2,836USD 2.64US$7,487Jun 16, 2026
Kumar Amit
Director, Officer: Chief Executive Officer
Buy21,000USD 2.50US$52,500Jun 12, 2026

Big stakes

HolderStakeSharesDate
Amit Kumar16.30%6.17MJun 4, 2025
Michael Catelani7.00%2.47MJan 5, 2026

Open Shareholders

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Amit Kumar
Other companies: Aeolus Pharmaceuticals Inc (Board Member · Since at least Nov 14, 2026)
Chief Executive Officer, Director · Since at least May 8, 2018
Bruce F Johnson
Other companies: CME Group Inc. (Director · May 25, 2006 – Aug 25, 2014 · Past)
Director · Aug 23, 2012 – Sep 22, 2017 · Past
David C. Cavalier
Other companies: Aeolus Pharmaceuticals Inc (Chairman · Since at least Jul 27, 2007)
Director · Sep 27, 2018 – Aug 13, 2020 · Past
John Monahan
Other companies: Theriva Biologics, Inc. (Director · Since at least Nov 11, 2020)
Director · Aug 23, 2016 – Aug 13, 2020 · Past
Kent B Williams
Other companies: Ener Core Inc (Director · Apr 14, 2017 – Apr 14, 2017 · Past)
Director · Aug 21, 2012 – May 28, 2014 · Past
Lewis H Titterton Jr
Other companies: ParkerVision, Inc. (Director · Since at least Sep 20, 2018)
Director · Since at least Aug 16, 2010
Richard H Williams
Other companies: Xspand Products Lab Inc (Director · Apr 4, 2018 – Apr 4, 2018 · Past)
Director · Sep 22, 2017 – Apr 9, 2018 · Past
Robert Berman
Other companies: enVVeno Medical Corporation (Chief Executive Officer and Director · Since at least May 30, 2018)
President & CEO, Director · Jul 1, 2013 – Jun 2, 2017 · Past
Andrea BelzDirector · Aug 8, 2014 – Feb 5, 2015 · Past
Arnold BaskiesDirector · Since at least Sep 27, 2018
All 20 people
PersonSeat
Dale FoxDirector · Aug 8, 2014 – Sep 6, 2017 · Past
Denis A KrusosChief Executive Officer, Director · Jun 1, 2006 – Oct 31, 2011 · Past
Emily GottschalkDirector · Since at least Oct 23, 2019
Frank J DisantoPresident, Director · Oct 6, 2006 – Nov 12, 2007 · Past
George P LarounisDirector · Oct 26, 2011 – Sep 5, 2012 · Past
Henry P HermsVP, Finance & CFO · Jan 2, 2006 – Oct 20, 2016 · Past
John H RoopSr. Vice President-Engineering · Sep 19, 2012 – Jan 24, 2014 · Past
Lew TittertonLead Independent Director · Since at least Oct 26, 2026
Michael CatelaniPresident, COO & CFO · Since at least Nov 1, 2016
Tisha StenderChief Operating Officer · Jul 8, 2014 – Jul 15, 2014 · Past

Open People

Log in to ask 6ix AI your own questions about Anixa Biosciences, Inc.